Concord Biotech: Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Wednesday February 11 2026

The Board of Directors of the Company at its meeting held today i.e. Wednesday February 11 2026 has inter-alia;1. UNAUDITED FINANCIAL RESULTS :On review and recommendation of Audit Committee of the Company the Board approved Unaudited Standalone and Consolidated Financial Results for the Third quarter and Nine months ended on December on 31 2025. 2. APPOINTMENT OF KEY MANAGERIAL PERSONNELOn the recommendation of the Nomination and Remuneration Committee the Board of Directors of the Company appointed Mr. Paritosh Trivedi (A63623) as Company Secretary Compliance Officer and Nodal Officer of the Company with effect from February 11 2026.